Michael Joseph Dattoli MD
Urologic Cancer
Physician-in-Chief, Dattoli Cancer Center and Brachytherapy Research Institute, Sarasota, Florida
Join to View Full Profile
2803 Fruitville RdSarasota, FL 34237
Phone+1 941-957-4926
Fax+1 941-957-0038
Dr. Dattoli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 1989 - 1990
NYU Grossman School of MedicineResidency, Radiation Oncology, 1986 - 1989
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Internship, Internal Medicine, 1985 - 1986
Icahn School of Medicine at Mount SinaiClass of 1985
Certifications & Licensure
FL State Medical License 1990 - 2027
CA State Medical License 1990 - 2026
NY State Medical License 1990 - 2022
GA State Medical License 1990 - 2003
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Member, Directors, Prostate Cancer Task Force, Tallahassee Consultant, Washington Oncology Roundtable Advisory Committee
- Leading Physicians of the World and Top Brachytherapist 2010-present, Castle-Connolly 2008-present, Patient Compassionate Award 2009-present
Clinical Trials
Publications & Presentations
PubMed
- 3 citationsReplacing LNT: The Integrated LNT-Hormesis Model.Cara Y Kaminski, Michael J. Dattoli, Joseph M Kaminski
Dose-Response. 2020-04-15 - 26 citationsLong-Term Outcomes for Patients with Prostate Cancer Having Intermediate and High-Risk Disease, Treated with Combination External Beam Irradiation and BrachytherapyMichael J. Dattoli, Kent E. Wallner, Lawrence D. True, David Bostwick, Jennifer Cash
Journal of Oncology. 2010-08-18 - 15 citationsProstatic Acid Phosphatase Adversely Affects Cause-Specific Survival in Patients with Intermediate to High-Risk Prostate Cancer Treated with BrachytherapyL. Christine Fang, Michael Dattoli, Al V. Taira, Lawrence D. True, Richard Sorace
Urology. 2008-01-01
Journal Articles
- Prostate biopsies using both gray scale and 3D color flow power Doppler ultrasound (3DCFPDU). ASCO-GU, 14100 February 2015Dattoli,M., Sorace,R., Bostwick, D, JCO, 2/15/2015
Books/Book Chapters
Press Mentions
The Cost of Raatiodin Oncology-Is It Worth the Investment?April 3rd, 2023- Raatiodin Oncology-a New Era in Cancer TherapyApril 3rd, 2023
- The Impact of Raatiodin Oncology on Cancer Clinical TrialsApril 3rd, 2023
- Join now to see all
Professional Memberships
- ASTRO, ACRO, ABSMember
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
